| Breakthrough Minerals Limited (BTM) ORDINARY FULLY PAID |
Energy |
$19 |
Breakthrough Secures High-Grade WA Gold Project
|
31 Mar 2025 9:58AM |
$0.075 |
$0.155 |
risen by
106.67%
|
|
BTM - Price-sensitive ASX Announcement
Full Release
Key Points
- Breakthrough Minerals to acquire the high-grade Errolls Gold Project.
- Historical production of 5,000oz at 17.6g/t Au with limited modern exploration.
- Shallow, high-grade intercepts from historical drilling include significant gold grades.
- Drill-ready status with plans to commence drilling immediately upon completion of the acquisition.
- Received binding commitments for a A$1.2 million placement to fund exploration.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Prescient Therapeutics Limited (PTX) ORDINARY FULLY PAID |
Health Care |
$59 |
Prescient Therapeutics - Investor Briefing
|
31 Mar 2025 9:58AM |
$0.048 |
$0.056 |
risen by
16.67%
|
|
| Firstwave Cloud Technology Limited (FCT) ORDINARY FULLY PAID |
Information Technology |
$6 |
Extension and Restructure of Fenja Capital Facility
|
31 Mar 2025 9:57AM |
$0.017 |
$0.003 |
fallen by
82.35%
|
|
FCT - Price-sensitive ASX Announcement
Full Release
Key Points
- FirstWave Cloud Technology Limited extends its finance facility with Fenja Capital Partners.
- The initial $2.5 million convertible note agreement has been modified to extend until October 2026.
- Fenja Capital's restructuring reflects confidence in FirstWave's growth strategy.
- New agreement includes a $2.125 million debt facility with attached warrants.
- Interest rate for the new facility is set at 12.11%.
- Restructuring aims to provide FirstWave greater cash flow and capital management flexibility.
- FirstWave focuses on expanding its presence in network management and cybersecurity.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Perpetual Limited (PPT) ORDINARY FULLY PAID |
Financials |
$1,862 |
Update - Dividend/Distribution - PPT
|
31 Mar 2025 9:57AM |
$20.050 |
$16.120 |
fallen by
19.60%
|
|
| Key Petroleum Limited (KEY) ORDINARY FULLY PAID |
Energy |
$2 |
Entitlement Offer Cleansing Notice
|
31 Mar 2025 9:57AM |
$0.062 |
$0.046 |
fallen by
25.81%
|
|
| Northern Minerals Limited (NTU) ORDINARY FULLY PAID |
Materials |
$239 |
Completion of Government share divestment order
|
31 Mar 2025 9:56AM |
$0.020 |
$0.025 |
risen by
25%
|
|
| ASX Limited (ASX) ORDINARY FULLY PAID |
Financials |
$9,509 |
ASX Responds to Actions from RBA and ASIC
|
31 Mar 2025 9:55AM |
$66.980 |
$48.940 |
fallen by
26.93%
|
|
| AuKing Mining Limited (AKN) ORDINARY FULLY PAID |
Materials |
$22 |
Cloncurry Project Update Tick Hill Gold Joint Venture
|
31 Mar 2025 9:54AM |
$0.007 |
$0.014 |
risen by
100%
|
|
AKN - Price-sensitive ASX Announcement
Full Release
Key Points
- Joint venture established for processing tailings at Tick Hill.
- Processing operation will be a 50/50 joint venture with THM.
- Preliminary Economic Assessment confirms the viability of tailings reprocessing.
- The 2020 Pre-Feasibility Study indicated a strong opportunity for gold production.
- Feasibility study to begin immediately with input from all parties.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Astral Resources NL (AAR) ORDINARY FULLY PAID |
Materials |
$315 |
MXR: Astral Issues Compulsory Acquisition Notice
|
31 Mar 2025 9:54AM |
$0.160 |
$0.175 |
risen by
9.37%
|
|
AAR - Price-sensitive ASX Announcement
Full Release
Key Points
- Astral has acquired approximately 90.5% of the shares in Maximus.
- A Compulsory Acquisition Notice was issued on 31 March 2025.
- Maximus' shares will be suspended from ASX trading five business days after the notice.
- Shareholders have until 4 April 2025 to accept the offer.
- Acceptance by shareholders will lead to accelerated consideration payments.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Maximus Resources Limited (MXR) ORDINARY FULLY PAID |
Materials |
- |
Astral Issues Compulsory Acquisition Notice
|
31 Mar 2025 9:54AM |
$0.080 |
$0.077 |
fallen by
3.75%
|
|
MXR - Price-sensitive ASX Announcement
Full Release
Key Points
- Astral has acquired approximately 90.5% of Maximus shares.
- Compulsory acquisition process will begin on 31 March 2025.
- Maximus shareholders must accept the offer by 4 April 2025.
- Shares will be suspended and removed from ASX if not accepted.
- Shareholders accepting the offer will receive accelerated consideration.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| African Gold Limited (A1G) ORDINARY FULLY PAID |
Materials |
$473 |
Impressive Drilling Results Continue to Deliver at Didievi
|
31 Mar 2025 9:54AM |
$0.120 |
$0.835 |
risen by
595.83%
|
|
A1G - Price-sensitive ASX Announcement
Full Release
Key Points
- Impressive drilling results from Didievi Gold Project.
- Confirmed continuity of mineralization at Blaffo Guetto High-Grade Zone.
- Significant assay results include 11m at 4.3g/t Au and 7m at 5.9g/t Au.
- Strategic partnership with Montage Gold enhances growth potential.
- Didievi Project located near major mining operations in Côte d'Ivoire.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| JPMorgan US 100Q Equity Premium Income Active ETF (Managed Fund) (Hedged) (JPHQ) |
Financials |
$11 |
Product Disclosure Statement
|
31 Mar 2025 9:53AM |
$56.080 |
$58.740 |
risen by
4.74%
|
|
| Franklin Global Growth Fund (Managed Fund) (FRGG) |
Financials |
$205 |
Quarterly Portfolio Holdings as at 31 January 2025
|
31 Mar 2025 9:53AM |
$2.540 |
$1.710 |
fallen by
32.68%
|
|
| Ventia Services Group Limited (VNT) ORDINARY FULLY PAID |
Industrials |
$4,570 |
Extension of Defence Base Services Contract
|
31 Mar 2025 9:53AM |
$4.110 |
$5.530 |
risen by
34.55%
|
|
VNT - Price-sensitive ASX Announcement
Full Release
Key Points
- Ventia extends Defence Base Services contract for 7 months.
- Contract value is approximately $270 million.
- Contract extension begins on July 1, 2025, and ends on January 31, 2026.
- Ventia has been supporting Defence for 35 years.
- CEO Dean Banks emphasizes commitment to service excellence for over 90,000 personnel.
- Base Services Transformation tender process is ongoing with expected outcomes this year.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Noronex Limited (NRX) ORDINARY FULLY PAID |
Materials |
$7 |
Option Exercise Raises $0.7M to Advance Copper Exploration
|
31 Mar 2025 9:53AM |
$0.019 |
$0.011 |
fallen by
42.11%
|
|
NRX - Price-sensitive ASX Announcement
Full Release
Key Points
- Option exercise proceeds of $710,703 have been received.
- Further funding of $750,000 is expected from an earn-in agreement with South 321.
- Diamond drilling to commence at the Fiesta Project in April.
- Funds will accelerate exploration across 100%-owned projects.
- The option exercise simplifies the company’s capital structure.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Nyrada Inc (NYR) CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED |
Health Care |
$122 |
First Cohort Dosed in Nyradas Phase I Clinical Trial
|
31 Mar 2025 9:52AM |
$0.110 |
$0.500 |
risen by
354.55%
|
|
NYR - Price-sensitive ASX Announcement
Full Release
Key Points
- First cohort of participants dosed in Nyrada's Phase I first-in-human clinical trial.
- Six participants received NYR-BI03 while two received placebo.
- Phase I trial designed to assess safety, tolerability and pharmacokinetics of NYR-BI03.
- All cohorts commence with sentinel participants for safety.
- Final Phase I trial readouts expected in 3QCY2025.
- Trial registered with US National Institutes of Health.
- NYR-BI03 is a first-in-class drug for neuroprotection and cardioprotection.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Gold Hydrogen Limited (GHY) ORDINARY FULLY PAID |
Energy |
$56 |
Pause in Trading
|
31 Mar 2025 9:50AM |
$0.620 |
$0.310 |
fallen by
50%
|
|
GHY - Price-sensitive ASX Announcement
Full Release
Key Points
- Trading in GHY securities is paused.
- The trading pause is pending a further announcement.
- This action is in compliance with ASX Listings requirements.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| GPT Group (GPT) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$8,735 |
Change of Director's Interest Notice - Russell Proutt
|
31 Mar 2025 9:50AM |
$4.430 |
$4.560 |
risen by
2.93%
|
|
| CurveBeam AI Limited (CVB) ORDINARY FULLY PAID |
Health Care |
$26 |
Vendor Validation of Enhanced HiRise in Final Stages
|
31 Mar 2025 9:49AM |
$0.120 |
$0.055 |
fallen by
54.17%
|
|
CVB - Price-sensitive ASX Announcement
Full Release
Key Points
- Vendor validation of enhanced HiRise for Robotic Surgery system is in final stages
- Matched HiRise and MDCT patient scans submitted met required performance criteria
- HiRise images meet or exceed MDCT metrics
- Further validation data and updated instructions provided to the vendor
- Company awaits vendor team's review and conclusion
- CEO expressed confidence in the submission
- Mutual interest to advance project quickly
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| JPMorgan US 100Q Equity Premium Income Active ETF (Managed Fund) (JPEQ) |
Financials |
$79 |
Product Disclosure Statement
|
31 Mar 2025 9:49AM |
$59.920 |
$56.900 |
fallen by
5.04%
|
|
| Gorilla Gold Mines Ltd (GG8) ORDINARY FULLY PAID |
Materials |
$242 |
Cleansing Notice
|
31 Mar 2025 9:49AM |
$0.475 |
$0.330 |
fallen by
30.53%
|
|
| Black Dragon Gold Corp (BDG) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
- |
Updated Scoping Study Salave Gold
|
31 Mar 2025 9:49AM |
$0.064 |
$0.086 |
risen by
34.38%
|
|
BDG - Price-sensitive ASX Announcement
Full Release
Key Points
- Salave Study reports total Mineral Resource expansion of more than 50% to 17.1Mt at 2.85 g/t Au for a total of 1.56 Moz contained Au
- Salave to generate after tax NPV of US$506 million and 34% IRR at a conservative assumed gold price of US$2106/oz
- Average forecast Annual Production boosted to 99,462oz Au in concentrate at an average grade of 59.7 g/t Au and gold recovery to concentrate rate of 97%
- Almost all financial and production metrics improved through new Scoping Study
- BDG expects at least half of estimated capital expenditure for Salave Project development will be invested in Asturias region
- Strengthens case for Salave as a Strategic Investment Project by the Asturias Government
- Clear pathway exists to pre-feasibility and feasibility studies over the next 12-24 months
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Terramin Australia Limited (TZN) ORDINARY FULLY PAID |
Materials |
$72 |
Date of AGM and Closing Date for Director Nominations
|
31 Mar 2025 9:49AM |
$0.078 |
$0.030 |
fallen by
61.54%
|
|
| Black Dragon Gold Corp (BDG) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
- |
Response to ASX Price Query
|
31 Mar 2025 9:48AM |
$0.064 |
$0.086 |
risen by
34.38%
|
|
BDG - Price-sensitive ASX Announcement
Full Release
Key Points
- BDG responded to ASX Price Query on 31 March 2025.
- The response addressed the Updated Scoping Study for Salave Gold Project.
- BDG confirmed reliance on Listing Rule 3.1A for confidentiality.
- The Updated Scoping Study was fast-tracked and announced.
- BDG confirmed compliance with ASX Listing Rules.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Grange Resources Limited (GRR) ORDINARY FULLY PAID |
Materials |
$220 |
Corporate Presentation
|
31 Mar 2025 9:48AM |
$0.210 |
$0.190 |
fallen by
9.52%
|
|